Genetic Signs Of Alcoholism Studied For The First Time In Women
Alcohol intake is a significant health and economic problem in Spain. Between 2% and 20% of the Spanish population are reckoned to be individuals who abuse alcohol intake, and even though it is not a unique problem since the aetiology of this imbalance has been established in genetics and in environmental variables, many studies have shown that there are genetic endowments that can confer greater susceptibility to alcoholism. For example, some variations in enzyme-encoding genes that break down the alcohol molecule are known to be closely associated with a higher intake, since they cause a variation in its metabolization rate which can be up to 30 times higher.
The pieces of research conducted by David Celorrio-Herrera of the BIOMICS research group at the UPV/EHU has focused on the study of different genetic variants in samples of the Spanish population for whom it has been possible to determine a statistically significant incidence in alcohol abuse. Specifically, the enzyme-encoding genes involved in the alcohol metabolization process and genes that encode receptors and enzymes linked to the dopaminergic system have been analysed. "The aetiology of addiction is due to a disorder in the system that regulates dopamine, since this neurotransmitter modulates the reward-response system in the brain," remarks Celorrio.
The incidence of single nucleotide polymorphisms (SNPs) - variations of a single "letter" on specific points of the gene - has been studied in all the cases. Within the family of metabolic genes the SNPs of the genes ADH1A-ADH1B-ADH1C, ADH4, ADH6, ALDH2 and CYP2E1 have been analysed; "70 % of the alcohol is broken down by enzymes encoded by these genes" points out Celorrio. Of the genes in the dopaminergic system, the SNPs analysed correspond to the genes TH, SLC18A2, DRD1, DRD2, DRD3, MAOA and COMT, "being the ones linked to the entire useful life of the dopamine: its production, delivery, action in the presence of receptors and destruction," adds the author. The incidence of the two families of genes has been analysed in two groups of population samples: 1-excessive consumers and 2-patients with dependence.
Among the excessive consumers, polymorphisms that significantly increase the risk associated with the hazardous intake of this substance were found in the ADH1B and DRD2 genes for both sexes and in the MAOA gene in women only. The analysis of the environmental variables together with the hazardous intake of alcohol displayed a high-risk profile: men, smokers, heavy consumers of meat and low consumers of fruit and vegetables, with occupations not requiring a high level of qualifications and physically not very active.
On the other hand, a significant association of alcohol dependence with polymorphisms in genes of the metabolism and dopaminergic route was observed with an SNP of the ADH1B gene in both sexes and with SNPs of TH, COMT, DRD2 in men only, whereas the association with DRD3 occurred in women alone.
The study of excessive consumers was carried out on a sample of 1,533 individuals (653 cases and 880 controls) originating in the EPIC (European Prospective Investigation into Cancer and Nutrition) project, of whom half were men and the other half women. The critical value of inclusion in this group was the intake of alcohol in excess of 70 g/day in men and 42 g/day in women, values very similar to the WHO classification for the group of "individuals with hazardous intake".
The large size of the sample enabled stratification by sex and adjustment by environmental variables which affect alcohol intake to be done, "which makes the results obtained highly reliable," explains Celorrio. "Until now, the Spanish Caucasian population has been studied by means of small samples and with very few women," he adds. The results relating to the metabolic genes have been published in the journal Addiction.
Due to obtainment difficulties, in the study on patients with dependence it was not possible to have such a large sample, so the author prudently stresses that the results obtained are not so conclusive. The gathering of these samples was conducted in collaboration with various alcoholism treatment centres: the Psychiatric Hospital of Vitoria-Gasteiz, the mental health clinics Novia Salcedo and Uribe-Kosta in Bizkaia, the Hospital Donostia in Donostia-San Sebastian and the Zuria Outpatients' Hospital for Drug Dependence in Iruñea-Pamplona, and were compiled over more than three years.
Association of alcohol dehydrogenase polymorphisms and life-style factors with excessive alcohol intake within the Spanish population (EPIC-Spain) Addiction. 2012 Dec; 107(12):2117-27. doi: 10.1111/j.1360-0443.2012.03970.x. Epub 2012 Aug 20
A comparison of Val81Met and other polymorphisms of alcohol metabolising genes in patients and controls in Northern Spain. Alcohol. 2012 Aug; 46(5):427-31. doi: 10.1016/j.alcohol.2012.03.003. Epub 2012 May 2.
Alcohol-Metabolizing Enzyme Gene Polymorphisms in the Basque Country, Morocco, and Ecuador. Alcohol Clin Exp Res. 2011 May; 35(5):879-84. doi: 10.1111/j.1530-0277.2010.01418.x. Epub 2011 Feb 8.
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
Fundazioa, Elhuyar. "Genetic Signs Of Alcoholism Studied For The First Time In Women." Medical News Today. MediLexicon, Intl., 21 Feb. 2013. Web.
24 Feb. 2017. <http://www.medicalnewstoday.com/releases/256581.php>
Fundazioa, E. (2013, February 21). "Genetic Signs Of Alcoholism Studied For The First Time In Women." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.